The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Prevalent expression of the immunostimulatory MHC class I chain–related molecule is counteracted by shedding in prostate cancer
Open accessAbstract
The MHC class I chain-related molecules (MICs) have previously been shown to be induced on most epithelial tumor cells. Engagement of MIC by the activating immune receptor NKG2D triggers NK cells and augments antigen-specific CTL anti-tumor immunity. The MIC-NKG2D system was proposed to participate in epithelial tumor immune surveillance. Paradoxically, studies suggest that tumors may evade MIC-NKG2D-mediated immunity by MIC shedding-induced impairment of effector cell function. Here we demonstrate the first evidence to our knowledge of a significant correlation of MIC shedding and deficiency in NK cell function with the grade of disease in prostate cancer. MIC is widely expressed in prostate carcinoma. The presence of surface target MIC, however, is counteracted by shedding. A significant increase in serum levels of soluble MIC (sMIC) and deficiency in NK cell function was shown in patients with advanced cancer. Finally, the deficiency in NK cell function can be overcome by treatment with IL-2 or IL-15 in vitro. Our results suggest that (a) deficiency in MIC-NKG2D immune surveillance may contribute to prostate cancer progression, (b) sMIC may be a novel biomarker for prostate cancer, and (c) using cytokines to restore MIC-NKG2D-mediated immunity may have clinical significance for prostate cancer in cell-based adaptive immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Self-citationTumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
Self-citationRoles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Self-citationRecognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
Groh, V., Steinle, A., Bauer, S., & Spies, T. (1998) · Science · doi:10.1126/science.279.5357.1737 · Cited by 1,142
Self-citationRae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H. (2000) · Nature Immunology · doi:10.1038/77793 · Cited by 878
Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
Self-citationCutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding
Salih, H. R., Rammensee, H.-G., & Steinle, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4098 · Cited by 643
Self-citationCerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
Curran, S., & Murray, G. I. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00156-8 · Cited by 531
Pende, D., Rivera, P., Marcenaro, S., Chang, C., Biassoni, R., Conte, R., Kubin, M. Z., Cosman, D. J., Ferrone, S., Moretta, L., et al. (2002) · PubMed · Cited by 500
Self-citationRole of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
Verneris, M. R., Karami, M., Baker, J., Jayaswal, A., & Negrin, R. S. (2004) · Blood · doi:10.1182/blood-2003-06-2125 · Cited by 383
On guard—activating NK cell receptors
Lanier, L. L. (2001) · Nature Immunology · doi:10.1038/83130 · Cited by 346
Roberts, A. I., Lee, L., Schwarz, E., Groh, V., Spies, T., Ebert, E. C., & Jabri, B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5527 · Cited by 335
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
Doubrovina, E. S., Doubrovin, M. M., Vider, E., Sisson, R. B., O’Reilly, R. J., Dupont, B., & Vyas, Y. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6891 · Cited by 324
Sutherland, C. L., Chalupny, N. J., Schooley, K., VandenBos, T., Kubin, M., & Cosman, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.671 · Cited by 276
Self-citationCarayannopoulos, L. N., Naidenko, O. V., Fremont, D. H., & Yokoyama, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4079 · Cited by 274
Wu, J., Groh, V., & Spies, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1236 · Cited by 257
Self-citationJinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Kimura, R., Miyagi, T., Mochizuki, K., Sasaki, Y., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10966 · Cited by 244
Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?
Vivier, E., Tomasello, E., & Paul, P. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00337-0 · Cited by 204
ULBP4 is a novel ligand for human NKG2D
Jan Chalupny, N., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A., & Cosman, D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00714-9 · Cited by 202
Self-citationMICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Bühring, H. ‐., DICHGANS, J., Rammensee, H., Steinle, A., et al. (2003) · PubMed · Cited by 193
Self-citationExpression of Stress-induced MHC Class I Related Chain Molecules on Human Melanoma
Vetter, C. S., Groh, V., Straten, P. T., Spies, T., Bröcker, E.-B., & Becker, J. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01700.x · Cited by 171
NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer
Cerwenka, A., & Lanier, L. L. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00070.x · Cited by 167
Transforming growth factor-? in benign and malignant prostate
Lee, C., Sintich, S. M., Mathews, E. P., Shah, A. H., KUNDU, S. D., Perry, K. T., Cho, J. S., Ilio, K. Y., Cronauer, M. V., Janulis, L., et al. (1999) · The Prostate · Cited by 151
PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCER
Troy, A., DAVIDSON, P., Atkinson, C. H., & Hart, D. N. J. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63093-3 · Cited by 151
Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line
Bae-Jump, V. L., Jackson‐Cook, C. K., Maygarden, S. J., Plymate, S. R., Chen, J., & Ware, J. L. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980301)34:4<275::aid-pros5>3.0.co;2-g · Cited by 118
Self-citationSteinle, A., Groh, V., & Spies, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12510 · Cited by 110
Self-citationNucleotide sequence of a human MHC class IMICB cDNA
Bahram, S., & Spies, T. A. (1996) · Immunogenetics · doi:10.1007/bf00587305 · Cited by 91
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. A. (2018) · The Journal of Immunology · doi:10.1093/jimmunol/200.7.2231 · Cited by 87
Self-citationThe NKG2D receptor and its ligands–recognition beyond the “missing self”?
Watzl, C. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00057-6 · Cited by 81
Bahram, S., & Spies, T. A. (1996) · Research in Immunology · doi:10.1016/0923-2494(96)89646-5 · Cited by 80
Conejo-Garcia, J. R., Benencia, F., Courreges, M. C., Gimotty, P. A., Khang, E., Buckanovich, R. J., Frauwirth, K. A., Zhang, L., Katsaros, D., Thompson, C. B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2194 · Cited by 80
Conejo-Garcia, J. R., Benencia, F., Courreges, M. C., Khang, E., Zhang, L., Mohamed-Hadley, A. A., Vinocur, J. M., Buckanovich, R. J., Thompson, C. B., Levine, B. L., et al. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.4.479 · Cited by 55
Wang, J., Torbenson, M. S., Wang, Q. I., Ro, J. Y., & Becich, M. J. (2003) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(02)00208-9 · Cited by 51
Uncoupling between Immunological Synapse Formation and Functional Outcome in Human γδ T Lymphocytes
Favier, B., Espinosa, É., Tabiasco, J., Santos, C. D., Bonneville, M., Valitutti, S., & Fournié, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5027 · Cited by 47
Prostate Specific Antigen Inhibits Immune Responses In Vitro: A Potential Role In Prostate Cancer
KENNEDY-SMITH, A. G., McKenzie, J. L., Owen, M. C., Davidson, P. J. T., Vučković, S., & Hart, D. N. J. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64738-6 · Cited by 33
Molinero, L. L., Fuertes, M. B., Fainboim, L., Rabinovich, G. A., & Zwirner, N. W. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602329 · Cited by 28
Cited by
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
NK cells and cancer: you can teach innate cells new tricks
Morvan, M. G., & Lanier, L. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.5 · Cited by 1,162
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Regulation of Ligands for the NKG2D Activating Receptor
Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W., & Jung, H. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095951 · Cited by 848
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Self-citation
Metadata
- Authors
- Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D., Haugk, K., & Plymate, S. R.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-08-16
- Volume
- 114
- Issue
- 4
- Pages
- 560-568
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1972814015
- Cited by
- 330
- References
- 42
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.